Klinikum Esslingen GmbH — Clinical Trial Site

88 Registered trials

43 Currently recruiting

Organisation

Klinikum Esslingen GmbH

Location

Esslingen Am Neckar, Germany

Identifier

ORG-100043190

Address

Hirschlandstraße 97, Oberesslingen, 73730, Germany

Departments

-
049021: Frauenheilkunde und Geburtshilfe
Allg. Innere Med., Onkologie, Hämatologie, Gastroenterologie und Infektiologie
Allgemein- und Viszeralchirurgie
Allgemeine Innere Medizin, Onkologie / Haematologie, Gastroenterologie und Infektiologie
Angiologie und Pneumologie
Cancer Center Esslingen
Cardiology, Angiology, Pneumology
Clinic for Cardiology, Angiology and Pneumology
Department for Gynecology and Obstetrics
Department of Cardiology, Angiology and Pulmonology
Department Oncology/Hematology, Gastroenterology and Infectious Diseases
Frauenklinik
Gynäkologisches Krebszentrum
Gynecology
Gynecology and Obstetrics
Hematology
Innere Medizin
Innere Medizin, Pneumologie
Innere Medizin/Hämatologie/Onkologie
Kardiologie, Angiologie und Pneumologie
Klinik fuer Frauenheilkunde und Geburtshilfe
Klinik fuer Kardiologie Angiologie und Pneumologie
Klinik fuer Kardiologie und Pneumologie
Klinik fuer Kardiologie, Angiologie Und Pneumologie
Klinik für Allgemeine Innere Medizin, Onkologie/Hämatologie,
Klinik für Allgemeine Innere Medizin, Onkologie/Hämatologie, Gastroenterologie und Infektiologie
Klinik für Allgemeine, Innere Medizin, Onkologie/Hämatologie, Gastroenterologie und Infektiologie
Klinik für Frauenheilkunde und Geburtshilfe
Klinik für Frauenheilkunde, Brustzentrum
Klinik für Kardiologie, Angiologie und Pneumologie
Klinik für Kardiologie, Angiologie und Pneumologie Studienbüro Haus 7
Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin
Klinik für Onkologie/Hämatologie
Klinikum Esslingen
n.a
n/a
Oncology
Onkologie & Hämatologie
Onkologie/ Hämatologie, Gastroenterologie und Infektiologie
Pneumologie
Pneumologie im Thoraxzentrum Südwest
Pneumologische Onkologie, Klinik für Kardiologie, Angiologie und Pneumologie
Pneumology
Thoraxzentrum Esslingen Stuttgart (TESS)
Thoraxzentrum Südwest

Clinical trials at this site (88)

Search interface

HARMONi-3 Not authorised

2023-504989-37-00 Metastatic Squamous Non-small Cell Lung Cancer 5
Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inh… Not authorised

2023-505311-20-00 Metastatic Non-Small Cell Lung Cancer 5
A trial to learn how well Dato-DXd and rilvegostomig work and how safe they are in participants with stage I adenocarcinoma non-small cell l… Pending

2024-512195-35-00 Stage I adenocarcinoma non-small cell lung cancer (NSCL 5
Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Ad… Pending

2025-521221-32-00 Advanced or Metastatic Non-Small Cell Lung Cancer 5
IZABRIGHT-Lung01: Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after… Pending

2025-521908-22-00 EGFR-mutated Non-small Cell Lung Cancer 10
PREFer Recruiting

2024-520138-31-00 Early-stage favorable classic Hodgkin lymphoma 4 2026-06-01
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing adjuvant Elacestrant with standard endocrine treatment in genomically and/… Recruiting

2025-522484-15-00 ER+/HER2- early breast cancer 5 2026-04-27
A Phase 2, randomized, multicenter, open-label neoadjuvant study evaluating zanidatamab in combination with chemotherapy in participants wit… Recruiting

2025-523204-68-00 HER2-positive breast cancer 4 2026-03-25
NoLEEta - Phase III non-inferiority trial of chemotherapy de-escalation in hormone receptorpositive, Her2-negative, intermediate-risk early … Recruiting

2025-520979-13-00 Patients with HR+ HER2- early breast cancer at intermed 5 2025-12-18
Osimertinib plus chemotherapy as 1st line therapy in stage IV NSCLC patients with atypical EGFR mutations (AIO-TRK/YMO-0324) Recruiting

2024-516790-78-00 stage IV NSCLC (non-small-cell lung cancer) 4 2025-09-04
A Study to Learn About the Study Medicine Called Sigvotatug Vedotin in People with Locally Advanced, Unresectable, or Metastatic Non-Small C… Recruiting

2024-517968-36-00 non-small cell lung cancer 5 2025-07-08
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab a… Recruiting

2023-505172-29-00 Resectable Non-small Cell Lung Cancer 4 2025-04-24
Mirvetuximab soravtansine in combination with bevacizumab for the maintenance treatment of adult patients with FRα-high recurrent platinum-s… Recruiting

2022-501606-35-01 Platinum-sensitive epithelial ovarian, fallopian tube, 11 2024-02-21
A Study of Repotrectinib versus Crizotinib in Participants with Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-po… Recruiting

2023-505604-32-00 Non small cell lung cancer (NSCLC) 5 2024-01-24
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III N… Recruiting

2023-503920-14-00 Non-Small Cell Lung Cancer (NSCLC) 5 2024-01-02
Evaluation of Niraparib alone compared to the combination of Niraparib and Bevacizumab in patients receiving chemotherapy for newly diagnose… Recruiting

2024-516066-11-00 Patients with newly diagnosed, histologically confirmed 5 2022-08-31
Beamion LUNG-3: A study to test whether zongertinib helps people with surgically removed, non-small cell lung cancer with HER2 mutations com… Recruiting

2025-521284-12-00 Non-small cell lung cancer 5 2026-03-05
Safety and efficacy of BNT327, an investigational therapy, in combination with chemotherapy for patients with untreated small-cell lung canc… Recruiting

2024-515765-34-00 English First-line extensive-stage small-cell lung canc 5 2026-02-04
Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), compared with Topotecan in… Recruiting

2025-521627-78-00 Neoplasms, Lung 5 2026-01-28
Trial of Trastuzumab Deruxtecan in Combination with Pembrolizumab Versus Pembrolizumab with Platinum-based Chemotherapy in First-line HER2 o… Recruiting

2024-515658-26-00 Unresectable or Metastatic HER2 overexpressing and PD-L 5 2026-01-21
A Study in TKI-naive Patients With Advanced ALK-Positive NSCLC ( ALKAZAR ) Recruiting

2024-517553-26-00 Advanced ALK-positive non-small cell lung cancer (NSCLC 5 2025-11-12
Study of Izalontamab Brengitecan (BMS-986507) versus Treatment of Physician’s Choice in Patients with Previously Untreated, Locally Advanced… Recruiting

2024-519871-24-00 Breast cancer 10 2025-11-11
TYPER Recruiting

2024-520290-12-00 Hormone receptor–positive (HRpos)/human epidermal growt 6 2025-11-04
A phase 2 placebo-controlled trial to investigate visugromab and nivolumab with or without docetaxel in second-line treatment of participant… Recruiting

2024-516794-70-00 Metastatic non-squamous non-small cell lung cancer 4 2025-11-03